Epidemiology and Assessment of Hair Loss among Adults in Sulaimani Governorate: A Sample Cohort Study
Keywords:
Androgenetic alopecia, Hair loss, PRP, oral supplement, Topical, IRAQAbstract
Background: Hair loss, a condition with significant psychological repercussions, is influenced by variousepidemiological factors. The present study aims to investigate epidemiological factors and evaluate hair
loss in adults in Sulaimani Province.
Method: This analytical cross-sectional cohort study was conducted in 2023. Multi-clinic centers across
Sulaimani City were selected for a follow-up study involving more than 150 participants. These individuals
were divided into three groups based on their treatment type: PRP (n = 50), topical applications (n=50), and
pharmacological treatments (n = 50). Each group was monitored over a period exceeding three months,
during which clinical and demographic data were meticulously gathered.
Result: The analysis of this study identified several risk factors for hair loss with varying odds ratios:
weight (OR = 1.33, 33%), height (OR = 1.01, 1%), body mass index (BMI) (OR = 1.008, 0.8%), familial
history of hair loss (OR = 1.10, 10%), recent surgical procedures (OR = 1.03, 3%), and history of anesthesia
(OR = 1.02, 2%). The treatments showcased effectiveness in reducing hair loss and were correlated with a
significant decrease in hair loss during every session. A noticeable reduction in daily hair loss was observed
among male and female participants in all therapy groups (PRP, topical, and pharmaceutical), indicating a
positive impact on mitigating hair loss through these treatment modalities.
Conclusion: This study's findings suggest that multiple factors contribute to hair loss. Identifying,
managing, and implementing timely interventions can significantly reduce hair loss. Interventions including
PRP therapy, topical treatments, and pharmacological approaches were effectively shown to reduce hair
loss in the study participants
References
Aukerman EL, Jafferany M. The psychological consequences of androgenetic alopecia: A
systematic review. J Cosmet Dermatol. 2023;22(1):89-95. https://doi.org/10.1111/jocd.14983
Frith H, Jankowski GS. Psychosocial impact of androgenetic alopecia on men: A
systematic review and meta-analysis. Psychol Health Med. 2024;29(4):822-42.
https://doi.org/10.1080/13548506.2023.2242049
Ahmed RS, Shakir SA, Mahdi AS, Noaman NG. Epidemiology of alopecia areata in
Baqubah city/Diyala-Iraq. Diyala Journal of Medicine. 2023;24(2):114-9.
https://doi.org/10.26505/DJM.24027260122
Hasanzadeh H, Nasrollahi SA, Halavati N, Saberi M, Firooz A. Efficacy and safety of 5%
minoxidil topical foam in male pattern hair loss treatment and patient satisfaction. Acta
Dermatovenerol Alp Pannonica Adriat. 2016;25(3):41-4.
https://doi.org/10.15570/actaapa.2016.12
Wambier CG, Vaño-Galván S, McCoy J, Gomez-Zubiaur A, Herrera S, Hermosa-Gelbard
Á, et al. Androgenetic alopecia present in the majority of patients hospitalized with COVID-19:
The "Gabrin sign". J Am Acad Dermatol. 2020;83(2):680-2.
https://doi.org/10.1016/j.jaad.2020.05.079
Panchaprateep R, Lueangarun S. Efficacy and Safety of Oral Minoxidil 5 mg Once Daily
in the Treatment of Male Patients with Androgenetic Alopecia: An Open-Label and Global
Photographic Assessment. Dermatol Ther (Heidelb). 2020;10(6):1345-57.
https://doi.org/10.1007/s13555-020-00448-x
Asadi S. The role of mutations on gene AR, in androgenetic alopecia syndrome. American
Journal of Molecular Biology. 2020;5:46-9. https://doi.org/10.15406/ijmboa.2020.05.00130
Lolli F, Pallotti F, Rossi A, Fortuna MC, Caro G, Lenzi A, et al. Androgenetic alopecia: a
review. Endocrine. 2017;57(1):9-17. https://doi.org/10.1007/s12020-017-1280-y
Tamashunas NL, Bergfeld WF. Male and female pattern hair loss: Treatable and worth
treating. Cleve Clin J Med. 2021;88(3):173-82. https://doi.org/10.3949/ccjm.88a.20014
Peyravian N, Deo S, Daunert S, Jimenez JJ. The Inflammatory Aspect of Male and Female
Pattern Hair Loss. J Inflamm Res. 2020;13:879-81. https://doi.org/10.2147/jir.S275785
Mysore V, Parthasaradhi A, Kharkar RD, Ghoshal AK, Ganjoo A, Ravichandran G, et al.
Expert consensus on the management of Androgenetic Alopecia in India. Int J Trichology.
;11(3):101-6. https://doi.org/10.4103/ijt.ijt_24_19
Umar S, Carter MJ. A Multimodal Hair-Loss Treatment Strategy Using a New Topical
Phytoactive Formulation: A Report of Five Cases. Case Rep Dermatol Med. 2021;2021:6659943.
https://doi.org/10.1155/2021/6659943
Grymowicz M, Rudnicka E, Podfigurna A, Napierala P, Smolarczyk R, Smolarczyk K, et
al. Hormonal Effects on Hair Follicles. Int J Mol Sci. 2020;21(15).
https://doi.org/10.3390/ijms21155342
Lanktree MB, Haghighi A, di Bari I, Song X, Pei Y. Insights into Autosomal Dominant
Polycystic Kidney Disease from Genetic Studies. Clin J Am Soc Nephrol. 2021;16(5):790-9.
https://doi.org/10.2215/cjn.02320220
World Medical Association Declaration of Helsinki. Ethical principles for medical
research involving human subjects. Bull World Health Organ. 2001;79(4):373-4.
Harries M, Macbeth AE, Holmes S, Chiu WS, Gallardo WR, Nijher M, et al. The
epidemiology of alopecia areata: a population‐based cohort study in UK primary care*. British
Journal of Dermatology. 2022;186(2):257-65. https://doi.org/10.1111/bjd.20628
Abd El Meged MM. Patterns of hair loss at Sohag University Hospital hair clinic. Sohag
Medical Journal. 2019;23(2):141-4.
Morinaga H, Mohri Y, Grachtchouk M, Asakawa K, Matsumura H, Oshima M, et al.
Obesity accelerates hair thinning by stem cell-centric converging mechanisms. Nature.
;595(7866):266-71. https://doi.org/10.1038/s41586-021-03624-x
Łukasik A, Kozicka K, Kłosowicz A, Jaworek A, Wojas-Pelc A. The role of family history
and its influence on the onset time in female pattern hair loss. Advances in Dermatology and
Allergology. 2020;38:815-8. https://doi.org/10.5114/ada.2020.100745
Phillips TG, Slomiany WP, Allison R. Hair Loss: Common Causes and Treatment. Am
Fam Physician. 2017;96(6):371-8.
Lee SH, Kang H, Lee WS. Association between Family History and Male Androgenetic
Alopecia with Female Pattern Hair Loss. Ann Dermatol. 2023;35(5):348-54.
https://doi.org/10.5021/ad.22.221
Arias EM, Floriach N, Moreno-Arias G, Camps A, Arias S, Trüeb RM. Targeted
Nutritional Supplementation for Telogen Effluvium: Multicenter Study on Efficacy of a
Hydrolyzed Collagen, Vitamin-, and Mineral-Based Induction and Maintenance Treatment. Int J
Trichology. 2022;14(2):49-54. https://doi.org/10.4103/ijt.ijt_57_21
Di Mascio D, Sapino G, De Maria F. Telogen Effluvium as a complication of scalp
reconstruction with tissue expander: a case report. Acta Biomed. 2021;92(S1):e2021431.
https://doi.org/10.23750/abm.v92iS1.12066
Lee H, Choi YW, Kim YC, Choi JW. Association between the first exposure to general
anesthesia and alopecia areata. J Dermatol. 2023;50(5):672-8. https://doi.org/10.1111/1346-
16712
Monil G, Snehal M, Veligandla KC, Rahul R, Gauri D, Bhavesh K, et al. Epidemiology
and Treatment Aspects of Hair Loss in India–A Cross-Sectional, Multicentre, Database Study
(HAILO). Asian Journal of Research in Dermatological Science. 2023;6(1):22-32.
York K, Meah N, Bhoyrul B, Sinclair R. A review of the treatment of male pattern hair
loss. Expert Opinion on Pharmacotherapy. 2020;21(5):603-12.
https://doi.org/10.1080/14656566.2020.1721463
Villani A, Fabbrocini G, Ocampo-Candiani J, Ruggiero A, Ocampo-Garza SS. Review of
oral minoxidil as treatment of hair disorders: in search of the perfect dose. Journal of the European
Academy of Dermatology and Venereology. 2021;35(7):1485-92.
https://doi.org/10.1111/jdv.17216
Minta A, Park C, Rose L, Trovato S, Dulmage B. Retrospective review of oral and topical
minoxidil for cancer treatment-induced hair loss. Archives of Dermatological Research.
;315(9):2613-5. https://doi.org/10.1007/s00403-023-02660-z
Gressenberger P, Pregartner G, Gary T, Wolf P, Kopera D. Platelet-rich Plasma for
Androgenetic Alopecia Treatment: A Randomized Placebo-controlled Pilot Study. Acta Derm
Venereol. 2020;100(15):adv00247. https://doi.org/10.2340/00015555-3609
Meyers A, Jin A, Kwiecien GJ, Gatherwright J, Khetarpal S, Zins JE. Platelet-Rich Plasma
for Treatment of Hair Loss Improves Patient-Reported Quality of Life. Aesthetic Plastic Surgery.
;47(4):1528-34. https://doi.org/10.1007/s00266-022-03224-8
Shapiro J, Ho A, Sukhdeo K, Yin L, Lo Sicco K. Evaluation of platelet-rich plasma as
a treatment for androgenetic alopecia: A randomized controlled trial. Journal of the American
Academy of Dermatology. 2020;83(5):1298-303. https://doi.org/10.1016/j.jaad.2020.07.006
Downloads
Published
Issue
Section
License
Copyright (c) 2024 University of Thi-Qar Journal Of Medicine
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.